Physician profile
Michael Bauer
NPI 1891057691
$32,791.26
in general payments reported to CMS, 2019-2025
6 companies · $9,047 in 2025
The $9,047 reported for 2025 was more than what 98% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.05 · 2022: $961 · 2023: $9,365 · 2024: $13K · 2025: $9,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $6,426 · Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,399.20 |
| Travel and Lodging | $6,425.62 |
| Food and Beverage | $975.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $32,564.11 | 2022-2025 | Iovera, Exparel, Zilretta |
| Biosense Webster, INC. | $124.22 | 2024 | Carto 3 |
| Avanos Medical | $32.98 | 2025 | Coolief Cooled Radiofrequency |
| Sunovion Pharmaceuticals INC. | $30.05 | 2019 | |
| Solventum Corporation | $23.54 | 2024 | V.A.C.Ulta, 3m Cavilon, Prevena |
| Hologic Sales and Service, LLC | $16.36 | 2025 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.